<DOC>
	<DOCNO>NCT02804308</DOCNO>
	<brief_summary>Breast cancer multifactorial disease affect woman , one treatment heal survival hormone therapy . Aromatase inhibitor third-generation drug promote low chance metastasis , side effect include loss bone mineral density increase fat percentage . In way , Combined Training ( combine resistance endurance training ) may interest strategy minimize side effect aromatase inhibitor , provide good quality life , survival change body composition .</brief_summary>
	<brief_title>Combined Training Body Composition Postmenopausal Women Undergoing Treatment Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Postmenopausal , define absence period past 12 month ; Breast cancer diagnosis stag 1 3 ; The adjuvant treatment breast cancer / neoadjuvant aromatase inhibitor No abnormality screen physical health problem contraindicate study participation ; No contraindication treadmill test entry training program , include follow : Myocardial infarction within past 6 month Pulmonary edema Myocarditis Pericarditis Unstable angina Pulmonary embolism deep vein thrombosis Uncontrolled hypertension ( i.e. , blood pressure &gt; 200/100 mm Hg ) Uncontrolled arrhythmia No significant mental illness Have medical certificate perform exercise test participate combine train Able answer Questionnaires No concurrent participation organize exercise program ; Live Presidente Prudente Sign consent form formal clarification participation study . Accumulating 3 unexcused absence 4 consecutive unexcused absence month .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Combined Training</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Body Composition</keyword>
	<keyword>Postmenopausal Women</keyword>
	<keyword>Aromatase Inhibitors</keyword>
	<keyword>Quality life</keyword>
</DOC>